Literature DB >> 7919371

Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells.

T Agui1, X Xin, Y Cai, T Sakai, K Matsumoto.   

Abstract

Endothelin (ET) produced by endothelial cells has recently been found to be a potent vasoconstricting hormone. In this report, ET is shown to be a potent stimulator of interleukin-6 (IL-6) production by rat bone marrow (BM)-derived stromal cells. It was also shown that ET increased the level of mRNA for IL-6 in these cells. The two types of ET receptor (R), ETAR and ETBR, were shown to be expressed on both BM-derived stromal cells in culture and ex vivo in BM tissue, suggesting that ET works as a physiologic stimulator of IL-6 production in the BM. It was shown that ETAR is coupled to phospholipase C activation, leading to the production of inositol 1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG) as second messengers in BM-derived stromal cells. This was corroborated by data showing that IL-6 production in these cells was induced by combined stimulation with ionomycin and phorbol myristate acetate, thereby bypassing the effects of IP3 and DAG, respectively. This is the first report on the hormonal regulation of IL-6 production by BM stromal cells, indicating that hematopoiesis is subject to endocrinologic regulation under physiologic conditions. ET has recently been reported to be produced by macrophages in response to bacterial lipopolysaccharide and human immunodeficiency virus-1 glycoprotein 120. These facts, taken together with our findings, raise the possibility that ET shares the same role of IL-1 as a local cytokine, mediating an intercellular signal between macrophages and BM stromal cells in response to bacterial or viral stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919371

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Off-pump myocardial revascularization attenuates endothelin-1 expression in systemic, pulmonary, and coronary circulation.

Authors:  Daniel Unić; Davor Barić; Kristina Brkić; Mislav Planinc; Dubravka Jonjić; Igor Rudež; Željko Sutlić
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 2.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

3.  Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line.

Authors:  L Speciale; K Roda; M Saresella; D Taramelli; P Ferrante
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

4.  ETB receptor contribution to vascular dysfunction in postmenopausal women.

Authors:  Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.